Medtronic STOP AF Results Show Efficacy, But Raise Some Safety Concerns
This article was originally published in The Gray Sheet
Executive Summary
Results of Medtronic's STOP AF trial show that 69.3% of patients treated with its Arctic Front cryoballoon catheter were free from atrial fibrillation at one year